Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee

NCT02187549 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02187549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Study of a Non-Crosslinked HA Alkylamide HYADD(TM) 4 Hydrogel for Osteoarthritis of the Knee
Lead sponsor
Fidia Farmaceutici s.p.a.
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2014
Completion date
March 31, 2016
Enrollment
332 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis